InsidersTradesSigma
선바이오: directors' dealings · South Korea · DART (FSS)
DART:company-7e1cf4KR·DART (FSS)Mcap 86.9Bn€Healthcare
Explore the full management transaction log of 선바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 선바이오 has logged 2 reports. Market capitalisation: €86.9bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 노광. The full history is openly available.
2
Insider Decl.
0
Thresholds
€58,369
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
7140.00 €
Analyst consensus
Income statement
Revenue13.67 Bn€
Gross profit8.34 Bn€61% margin
Net income2.79 Bn€64.2% margin
Valuation
Beta0.77
Balance sheet & cash
Market cap86.86 Bn€
Total debt28.41 Bn€
Free Cash Flow576.6 M€
Profitability & ownership
ROE35.4%
ROA4.6%
% insiders31.7%
% institutions0.0%
Last declaration on 27 March 2026
Declarations2 total
2 of 2 declarations